Augustine Asset Management Inc Regeneron Pharmaceuticals, Inc. Transaction History

Augustine Asset Management Inc

$320 Million
Q1 2025

A detailed history of Augustine Asset Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Augustine Asset Management Inc holds 4,469 shares of REGN stock, worth $2.28 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares

4,469

Previous 4,474 0.11%

Holding current value

$2.28 Million

Previous $3.19 Million 11.05%

% of portfolio

0.89%

Previous 0.9%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	SELL	$634.14 - $744.83 $3,170 - $3,724	-5 Reduced 0.11%	4,469 $2.83 Million
Q4 2024 Jan 29, 2025	SELL	$701.85 - $1046.91 $47,725 - $71,189	-68 Reduced 1.5%	4,474 $3.19 Million
Q3 2024 Oct 25, 2024	SELL	$1024.09 - $1201.76 $14,337 - $16,824	-14 Reduced 0.31%	4,542 $4.77 Million
Q2 2024 Aug 01, 2024	BUY	$883.2 - $1071.19 $18,547 - $22,494	21 Added 0.46%	4,556 $4.79 Million
Q1 2024 Apr 26, 2024	SELL	$902.69 - $993.35 $9,929 - $10,926	-11 Reduced 0.24%	4,535 $4.36 Million
Q4 2023 Jan 24, 2024	BUY	$775.18 - $881.7 $165,888 - $188,683	214 Added 4.94%	4,546 $3.99 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $94,173 - $114,834	-136 Reduced 3.04%	4,332 $3.57 Million
Q2 2023 Jul 24, 2023	SELL	$700.03 - $830.35 $7,000 - $8,303	-10 Reduced 0.22%	4,468 $3.21 Million
Q1 2023 May 01, 2023	SELL	$680.49 - $826.97 $17,692 - $21,501	-26 Reduced 0.58%	4,478 $3.68 Million
Q4 2022 Feb 09, 2023	SELL	$705.89 - $766.39 $65,647 - $71,274	-93 Reduced 2.02%	4,504 $3.25 Million
Q3 2022 Oct 24, 2022	BUY	$573.97 - $724.32 $2,295 - $2,897	4 Added 0.09%	4,597 $3.17 Million
Q2 2022 Aug 02, 2022	SELL	$548.35 - $738.84 $203,986 - $274,848	-372 Reduced 7.49%	4,593 $2.72 Million
Q1 2022 Apr 27, 2022	SELL	$595.12 - $698.43 $6,546 - $7,682	-11 Reduced 0.22%	4,965 $3.47 Million
Q4 2021 Feb 01, 2022	BUY	$543.48 - $670.97 $22,282 - $27,509	41 Added 0.83%	4,976 $3.14 Million
Q3 2021 Oct 26, 2021	SELL	$574.03 - $680.96 $61,421 - $72,862	-107 Reduced 2.12%	4,935 $2.99 Million
Q2 2021 Jul 20, 2021	SELL	$472.8 - $558.54 $99,760 - $117,851	-211 Reduced 4.02%	5,042 $2.82 Million
Q1 2021 May 05, 2021	BUY	$446.73 - $548.2 $17,422 - $21,379	39 Added 0.75%	5,253 $2.49 Million
Q4 2020 Jan 26, 2021	SELL	$478.3 - $607.98 $6,696 - $8,511	-14 Reduced 0.27%	5,214 $2.52 Million
Q3 2020 Oct 21, 2020	SELL	$544.75 - $658.21 $193,931 - $234,322	-356 Reduced 6.38%	5,228 $2.93 Million
Q2 2020 Jul 15, 2020	BUY	$493.32 - $643.92 $1.09 Million - $1.43 Million	2,218 Added 65.89%	5,584 $3.48 Million
Q1 2020 Apr 21, 2020	BUY	$336.18 - $494.43 $1.13 Million - $1.66 Million	3,366 New	3,366 $1.64 Million

Others Institutions Holding REGN

# of Institutions

1,471

Shares Held

85.8M

Call Options Held

1.39M

Put Options Held

1.45M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $54.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Augustine Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Augustine Asset Management Inc with notifications on news.

Account

Augustine Asset Management Inc Regeneron Pharmaceuticals, Inc. Transaction History